title: Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion.
abstract: Owing to a striking, and most likely fortuitous, structural and sequence similarity with the bacterial 16 S ribosomal A site, the RNA kissing-loop complex formed by the HIV-1 genomic RNA dimerization initiation site (DIS) specifically binds 4,5-disubstituted 2-deoxystreptamine (2-DOS) aminoglycoside antibiotics. We used chemical probing, molecular modeling, isothermal titration calorimetry (ITC) and UV melting to investigate aminoglycoside binding to the DIS loop-loop complex. We showed that apramycin, an aminoglycoside containing a bicyclic moiety, also binds the DIS, but in a different way than 4,5-disubstituted 2-DOS aminoglycosides. The determination of thermodynamic parameters for various aminoglycosides revealed the role of the different rings in the drug-RNA interaction. Surprisingly, we found that the affinity of lividomycin and neomycin for the DIS (K(d) approximately 30 nM) is significantly higher than that obtained in the same experimental conditions for their natural target, the bacterial A site (K(d) approximately 1.6 microM). In good agreement with their respective affinity, aminoglycoside increase the melting temperature of the loop-loop interaction and also block the conversion from kissing-loop complex to extended duplex. Taken together, our data might be useful for selecting new molecules with improved specificity and affinity toward the HIV-1 DIS RNA.
authors.affiliation: Architecture et Réactivité des ARN, UPR 9002 CNRS, Université Louis Pasteur, Institut de Biologie Moléculaire et Cellulaire, 15 rue René Descartes, 67084 Strasbourg, France.
authors.forename: Serena
authors.initials: S
authors.lastname: Bernacchi
authors.forename: Séverine
authors.initials: S
authors.lastname: Freisz
authors.forename: Clarisse
authors.initials: C
authors.lastname: Maechling
authors.forename: Bernard
authors.initials: B
authors.lastname: Spiess
authors.forename: Roland
authors.initials: R
authors.lastname: Marquet
authors.forename: Philippe
authors.initials: P
authors.lastname: Dumas
authors.forename: Eric
authors.initials: E
authors.lastname: Ennifar
mesh_terms: D020121:5' Untranslated Regions / Q000737:chemistry*; D000617:Aminoglycosides / Q000737:chemistry*; D000900:Anti-Bacterial Agents / Q000737:chemistry; D000998:Antiviral Agents / Q000737:chemistry*; D001665:Binding Sites; D002151:Calorimetry; D002934:Cinnamates / Q000737:chemistry; D019281:Dimerization; D015497:HIV-1 / Q000235:genetics*; D006921:Hygromycin B / Q000031:analogs & derivatives / Q000737:chemistry; D008958:Models, Molecular; D009328:Nebramycin / Q000031:analogs & derivatives / Q000737:chemistry; D009690:Nucleic Acid Conformation; D010303:Paromomycin / Q000031:analogs & derivatives / Q000737:chemistry; D012367:RNA, Viral / Q000737:chemistry*; D013816:Thermodynamics
chemical_list: D020121:5' Untranslated Regions; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D002934:Cinnamates; D012367:RNA, Viral; D009328:Nebramycin; C011666:apramycin; D006921:Hygromycin B; C026273:hygromycin A; D010303:Paromomycin; C100306:lividomycin